Sana Biotechnology, Inc. (SANA) Misses Q4 EPS by 7c

Sana Biotechnology, Inc. (NASDAQ: SANA) reported Q4 EPS of ($0.21), $0.07 worse than the analyst estimate of ($0.14).

For earnings history and earnings-related data on Sana Biotechnology, Inc. (SANA) click here.

You May Also Be Interested In

• Kura Oncology (KURA) Reiterated at Market Outperform by Citizens Post Q2 Results
• Raymond James Downgrades Weave Communications Inc (WEAV) to Market Perform
• Trend Micro Incorporated (4704:JP) (TMICY) PT Lowered to JPY5,900 at Goldman Sachs